Retinitis Pigmentosa
Cytomegalovirus Retinitis
Retinitis
Rhodopsin
Eye Infections, Viral
Retinal Degeneration
Photoreceptor Cells, Vertebrate
Foscarnet
Genes, Dominant
Retina
Pedigree
Ganciclovir
Fundus Oculi
Visual Acuity
AIDS-Related Opportunistic Infections
Peripherins
Genetic Diseases, X-Linked
Dark Adaptation
Photoreceptor Cells
Cyclic Nucleotide Phosphodiesterases, Type 6
Visual Fields
Retinal Rod Photoreceptor Cells
Retinal Necrosis Syndrome, Acute
Night Blindness
Usher Syndromes
Retinal Cone Photoreceptor Cells
Mutation
Genetic Linkage
Vitreous Body
Blindness
Cytomegalovirus
Rod Opsins
Visual Field Tests
Fluorescein Angiography
Antiviral Agents
X Chromosome
Vision Disorders
Exons
Mutation, Missense
Eye Diseases, Hereditary
Tomography, Optical Coherence
Acquired Immunodeficiency Syndrome
Herpes Zoster Ophthalmicus
Interleukin-10 Receptor alpha Subunit
Molecular Sequence Data
IMP Dehydrogenase
Uveitis
Fovea Centralis
Leber Congenital Amaurosis
Laurence-Moon Syndrome
Chorioretinitis
Eye Infections
Ribonucleoprotein, U4-U6 Small Nuclear
Retinal Dysplasia
Cytomegalovirus Infections
Polymorphism, Single-Stranded Conformational
Retinal Photoreceptor Cell Outer Segment
Tetraspanins
Lod Score
Phenotype
Intermediate Filament Proteins
Polymerase Chain Reaction
Photoreceptor Connecting Cilium
Chromosome Mapping
Disease Models, Animal
Frameshift Mutation
Organophosphonates
Opsins
Organophosphorus Compounds
Macula Lutea
Toxoplasmosis, Ocular
Muromegalovirus
Base Sequence
CD4 Lymphocyte Count
Optic Atrophy, Hereditary, Leber
Amino Acid Sequence
Phosphenes
Vision, Ocular
Heterozygote
Ataxia
Macular Edema
Drug Implants
Intravitreal Injections
Pigment Epithelium of Eye
Sequence Analysis, DNA
Bardet-Biedl Syndrome
Retinal Dystrophies
Codon, Nonsense
Point Mutation
Retinal Pigment Epithelium
Genotype
Retinal Detachment
Cilia
Vision, Low
Antiretroviral Therapy, Highly Active
Anterior Chamber
Murine Acquired Immunodeficiency Syndrome
Rod Cell Outer Segment
Rats, Transgenic
Visual Prosthesis
Fluorescent Antibody Technique, Indirect
Ophthalmoscopes
Electrooculography
Aqueous Humor
Carrier Proteins
Arrestin
Optic Atrophies, Hereditary
Eye
RNA Splicing
Retinal Bipolar Cells
Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. (1/365)
The photopathology of retinal lesions produced by extended exposure (1000 sec) to low corneal power levels (62 microW) of blue light (441 nm) was investigated by light microscopy in 20 rhesus eyes over an interval ranging from 1 hr to 90 days after exposure. Results indicate a nonthermal type of photochemical lesion originating in the retinal pigment epithelium and leading to a histological response with hypopigmentation which requires 48 hr to appear. This type of lesion helps to explain solar retinitis and eclipse blindness and has significance for aging and degenerative changes in the retina. (+info)Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity. (2/365)
PURPOSE: Experimental autoimmune uveoretinitis (EAU) is a cell-mediated model of retinal autoimmunity that is negatively regulated by interleukin (IL)-10. The antidepressant drug rolipram, a type IV phosphodiesterase inhibitor, enhances IL-10 production by monocyte/macrophages. The effect of rolipram on induction of EAU and its associated immunologic responses was investigated. METHODS: Mice were challenged for EAU induction by immunization with the retinal antigen interphotoreceptor retinoid-binding protein (IRBP) or by adoptive transfer of uveitogenic T cells and were treated with rolipram. EAU severity and immunologic responses to IRBP were analyzed. In addition, the effect of rolipram added to the culture on antigen-driven responses of primed lymph node cells was tested. RESULTS: Rolipram treatment from days -1 to 7 after immunization (afferent phase) was not protective, but severity of EAU was reduced to 50% by treatment from days 8 to 16 after immunization or when EAU was induced by adoptive transfer (efferent phase). Antigen-specific proliferation and interferon (IFN)-gamma production ex vivo by lymph node cells of protected mice were not reduced. However, the addition of rolipram directly to the culture suppressed IRBP-driven proliferation and IFN-gamma production by primed lymph node cells. Freshly explanted lymph node cells of treated mice showed inhibition of IFN-gamma mRNA but no parallel enhancement of IL-10 mRNA by quantitative polymerase chain reaction. Rolipram inhibited EAU in IL-10 knockout mice equally well compared with controls and suppressed their primed lymph node cells in culture. CONCLUSIONS: Rolipram appears to inhibit the expansion and effector function of uveitogenic T cells, raising the possibility that it may be useful for treatment of established disease. Contrary to expectations based on in vitro studies, the protective effects in vivo appear to be independent of IL-10. The observation that suppression of antigen-specific responses is demonstrable only in the physical presence of the drug suggests that, in a clinical setting, continuous administration of rolipram might be needed to sustain its therapeutic effect. (+info)Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. (3/365)
Cytomegalovirus (CMV) DNA loads in paired leukocyte and plasma samples from 199 patient visits by 66 patients with CMV retinitis were determined. Leukocyte CMV load determinations had a greater range of values (mean, 24,587 copies/10(6) leukocytes; maximum, 539, 000) than did plasma CMV load determinations (mean, 10,302 copies/ml; maximum, 386,000), and leukocyte viral loads were detectable in a greater proportion of patients at the time of diagnosis of CMV retinitis prior to initiation of anti-CMV therapy (82%) than were plasma viral loads (64%) (P = 0.0078). Agreement with CMV blood cultures was slightly better for plasma (kappa = 0. 68) than for leukocytes (kappa = 0.53), due to a greater proportion of patients with detectable viral loads in leukocytes having negative blood cultures. (+info)Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis. (4/365)
PURPOSE: Nitric oxide (NO) is an important mediator of inflammatory tissue damage. The present study addresses the question whether inducible nitric oxide synthase (iNOS), and consequently the ability to upregulate NO, is required to effect the pathogenesis of experimental autoimmune uveoretinitis (EAU) in mice. METHODS: Mice with a homologous disruption of the iNOS gene (iNOS KO) were evaluated for their ability to develop EAU and associated cellular responses after immunization with the interphotoreceptor retinoid-binding protein. EAU was determined by histopathology 21 days after uveitogenic immunization, and antigen-specific cellular responses were assessed by delayed type hypersensitivity and lymphocyte proliferation. RESULTS: iNOS knockout (iNOS KO) mice developed EAU with scores similar to wild-type mice and exhibited good cellular responses to the immunizing antigen. CONCLUSIONS: A functional iNOS gene is not necessary for EAU pathogenesis. Therefore, upregulation of NO is not required to mediate autoimmune tissue damage in the eye. (+info)Identification of genomic regions controlling experimental autoimmune uveoretinitis in rats. (5/365)
The present study attempts to identify specific genetic loci contributing to experimental autoimmune uveoretinitis (EAU) susceptibility in F2 progeny of resistant Fischer (F344/N) and susceptible Lewis (LEW/N) inbred rats. F2 progeny of F344/N x LEW/N inbred rats were immunized with the R16 peptide of interphotoreceptor retinoid-binding protein (IRBP). A genome-wide scan was conducted using 125 simple sequence length polymorphism markers in selected F2 animals that developed severe eye disease or remained unaffected to identify phenotype:genotype co-segregation. The F2 population (n = 1287) demonstrated a wide range of histologically assessed EAU scores (assessed on a scale of 0-4). The disease incidence and severity were not consistent with a simple Mendelian inheritance model. Of the F2 hybrid rats, 60% developed EAU, implying the existence of a potent susceptibility locus with incomplete penetrance associated with the LEW genome or a more complex polygenic model of inheritance. Two genomic regions, on chromosomes 4 and 12, showed strong genetic linkage to the EAU phenotype (P < 0.0016), suggesting the presence of susceptibility loci in these chromosomal regions. In conclusion, we have identified two genomic candidate intervals from D4Arb8 to D4Mit17 on chromosome 4 and from the chromosome end to D12Arb8 on chromosome 12, that appear to influence EAU susceptibility in LEW/F344 rats. Further analysis of these genomic regions may lead to identification of the susceptibility genes and to characterization of their function. (+info)Role of retinal vascular endothelial cells in development of CMV retinitis. (6/365)
PURPOSE: Although cytomegalovirus (CMV) retinitis is known to occur in association with retinal microangiopathy in individuals with marked immunodeficiency, glial cells are believed to be the initial target cells in the development of retinitis. Moreover, it has been hypothesized that CMV gains access to the retinal glia because of altered vascular permeability. In an attempt to address the hypothesis, we studied 30 autopsy eyes of AIDS patients with systemic CMV infection, with or without clinically apparent CMV retinitis. METHODS: The autopsy eyes were processed in three ways. First, dual immunohistochemical studies were done by using anti-CMV antibodies for immediate early, early, and late antigens. The retinal cell types infected with the virus were then determined by using anti-GFAP, anti-VonWillebrand's factor, neuronal specific enolase, and leukocyte marker CD68. Second, selected eyes were processed for in situ hybridization with DNA probe specific to CMV. Third, an eye with clinically apparent CMV retinitis was submitted for electron microscopic examination. RESULTS: At the site of retinal necrosis in those eyes with a clinical diagnosis of CMV retinitis, the immunohistochemical, in situ hybridization, and ultrastructural examinations revealed that CMV was present primarily in the Muller cells and in perivascular glial cells. Adjacent to these infected cells, focal areas of positive staining for CMV antigen were seen in the glial cells, neuronal cells, and retinal pigment epithelial cells. At these sites most of the retinal capillaries were devoid of endothelial cells. Few vessels located at the advancing margin of retinal necrosis showed the presence of viral proteins in the endothelial cells. CONCLUSIONS: The present results indicate that retinal vascular endothelial cells could be the initial target in the development of viral retinitis, with subsequent spread of the infection to perivascular glia, Muller cells, and other retinal cells, including the retinal pigment epithelium. (+info)Presumed ocular bartonellosis. (7/365)
BACKGROUND: The spectrum of diseases caused by Bartonella henselae continues to expand and ocular involvement during this infection is being diagnosed with increasing frequency. METHODS: The clinical features and visual prognosis for 13 patients with intraocular inflammatory disease and laboratory evidence of bartonellosis were investigated. There were nine patients with neuroretinitis and four with panuveitis with positive antibody titres against B henselae determined by an enzyme immunoassay (IgG exceeding 1:900 and/or IgM exceeding 1:250). RESULTS: Positive IgG levels were found for eight patients and positive IgM levels for five. Despite animal exposure of 10 patients, only two (IgG positive) cases had systemic symptoms consistent with the diagnosis of cat scratch disease. Pathological fluorescein leakage of the optic disc was observed in all affected eyes. At 6 months' follow up, 3/18 (17%) affected eyes had a visual acuity of less than 20/100, owing to optic disc atrophy and cystoid macular oedema. 12 patients (17 eyes) were treated with antibiotics; visual acuity improved two or more Snellen lines for 9/17 (53%) eyes. CONCLUSIONS: The possibility of B henselae infection should be considered in patients with neuroretinitis and panuveitis (especially in cases with associated optic nerve involvement) even in the absence of systemic symptoms typical for cat scratch disease. (+info)AIDS related eye disease in Burundi, Africa. (8/365)
AIMS: To determine the prevalence of ocular manifestations in AIDS patients hospitalised in Bujumbura, Burundi, according to their CD4+ lymphocyte count, serological status for CMV and VZV, and general health status. METHODS: Prospective study of 154 consecutive patients who underwent general and ophthalmological examinations, including dilated fundus examination. AIDS was diagnosed on the basis of Bangui criteria and HIV-1 seropositivity. CD4+ lymphocyte counts were determined by the Capcellia method. CMV and VZV antibodies were detected with ELISA methods. RESULTS: The mean age was 37 (SD 9) years and 65% of the patients were male. Active tuberculosis was the most frequent underlying disease (61%). Almost all the patients (99%) were seropositive for CMV and VZV. Among the 115 patients for whom CD4+ lymphocyte counts were available, 86 (75%) had more than 100 cells x 10(6)/l. Ocular involvement comprised 16 cases of microangiopathy, six of opalescence of the anterior chamber, five of retinal perivasculitis, two of zoster ophthalmicus, two of viral retinitis, and one of opalescence of the vitreous. CONCLUSION: In Africa, the prevalence of ocular involvement in HIV infection is far lower than in Europe and the United States, possibly because most African patients die before ocular opportunistic infections occur. (+info)The symptoms of RP can vary depending on the severity of the condition and the specific genetic mutations causing it. Common symptoms include:
* Night blindness
* Difficulty seeing in low light environments
* Blind spots or missing areas in central vision
* Difficulty reading or recognizing faces
* Sensitivity to light
* Reduced peripheral vision
* Blurred vision
There is currently no cure for RP, and treatment options are limited. However, researchers are actively working to develop new therapies and technologies to slow the progression of the disease and improve the quality of life for individuals with RP. These include:
* Gene therapy: Using viral vectors to deliver healthy copies of the missing gene to the retina in an effort to restore normal vision.
* Stem cell therapy: Transplanting healthy stem cells into the retina to replace damaged or missing cells.
* Pharmacological interventions: Developing drugs that can slow down or reverse the progression of RP by targeting specific molecular pathways.
* Retinal implants: Implanting a retinal implant, such as a retinal prosthetic, to bypass damaged or non-functional photoreceptors and directly stimulate the visual pathway.
It's important to note that these therapies are still in the experimental stage and have not yet been proven effective in humans. Therefore, individuals with RP should consult with their healthcare provider about the best treatment options available.
In summary, Retinitis Pigmentosa is a genetic disorder that causes progressive vision loss, particularly during childhood or adolescence. While there is currently no cure for RP, researchers are actively working to develop new therapies to slow down or restore vision in those affected by the disease. These include gene therapy, stem cell therapy, pharmacological interventions, and retinal implants. It's important to consult with a healthcare provider for the best treatment options available.
FAQs:
1. What is Retinitis Pigmentosa?
Retinitis Pigmentosa (RP) is a genetic disorder that causes progressive vision loss, typically during childhood or adolescence.
2. What are the symptoms of Retinitis Pigmentosa?
Symptoms of RP can vary depending on the specific mutation causing the disease, but common symptoms include difficulty seeing at night, loss of peripheral vision, and difficulty adjusting to bright light.
3. Is there a cure for Retinitis Pigmentosa?
Currently, there is no cure for RP, but researchers are actively working on developing new therapies to slow down or restore vision in those affected by the disease.
4. What are some potential treatments for Retinitis Pigmentosa?
Some potential treatments for RP include gene therapy, stem cell therapy, pharmacological interventions, and retinal implants. It's important to consult with a healthcare provider for the best treatment options available.
5. Can Retinitis Pigmentosa be prevented?
RP is a genetic disorder, so it cannot be prevented in the classical sense. However, researchers are working on developing gene therapies that can prevent or slow down the progression of the disease.
6. How does Retinitis Pigmentosa affect daily life?
Living with RP can significantly impact daily life, especially as vision loss progresses. It's important to adapt and modify daily routines, such as using assistive devices like canes or guide dogs, and seeking support from family and friends.
7. What resources are available for those affected by Retinitis Pigmentosa?
There are a variety of resources available for those affected by RP, including support groups, advocacy organizations, and online communities. These resources can provide valuable information, support, and connections with others who understand the challenges of living with the disease.
The infection occurs when the virus enters the retina and causes inflammation, which can lead to damage to the retinal cells and blood vessels. Symptoms of CMV retinitis may include blurred vision, sensitivity to light, and floaters. If left untreated, the infection can progress to scarring, retinal detachment, and blindness.
The diagnosis of CMV retinitis is based on a combination of clinical findings, including symptoms, physical examination, and imaging tests such as fluorescein angiography. Treatment typically involves antiviral medication to suppress the virus and prevent further damage to the retina. In severe cases, surgery may be necessary to remove inflamed tissue or repair damaged blood vessels.
Preventing CMV retinitis in high-risk individuals, such as those with HIV/AIDS or undergoing immunosuppressive therapy, is important to avoid vision loss. This includes regular monitoring for CMV infection and prompt treatment if an infection occurs. In addition, reducing the risk of HIV transmission through safe sex practices and needle exchange programs can also help prevent CMV retinitis in these individuals.
Overall, CMV retinitis is a serious complication of viral infection that can cause significant vision loss if left untreated. Early detection and prompt treatment are essential to prevent long-term visual impairment and improve outcomes for patients with this condition.
There are several types of retinitis, including:
1. Retinitis pigmentosa: This is a group of inherited conditions that cause progressive vision loss due to degeneration of the retina.
2. Cytomegalovirus (CMV) retinitis: This is a type of retinitis caused by the CMV virus, which is common in people with weakened immune systems, such as those with HIV/AIDS.
3. Toxoplasma retinitis: This is a type of retinitis caused by the Toxoplasma gondii parasite, which can cause vision loss if left untreated.
4. Syphilitic retinitis: This is a type of retinitis caused by the bacteria Treponema pallidum, which can cause vision loss if left untreated.
5. Uveitis-related retinitis: This is a type of retinitis that occurs as a complication of uveitis, an inflammation of the uvea, the middle layer of the eye.
Symptoms of retinitis can include vision loss, blurred vision, sensitivity to light, and floaters (specks or cobwebs in your vision). If you experience any of these symptoms, it is important to seek medical attention as soon as possible.
Retinitis is typically diagnosed through a combination of physical examination, imaging tests such as optical coherence tomography (OCT), and laboratory tests to identify the underlying cause. Treatment for retinitis depends on the underlying cause and may include antiviral or antibacterial medications, immunosuppressive drugs, or surgery. In some cases, vision loss may be permanent, but early diagnosis and treatment can help prevent further damage and improve outcomes.
Some common types of viral eye infections include:
1. Conjunctivitis caused by adenovirus: This is a highly contagious form of conjunctivitis that often affects children and can be spread through close contact with an infected person or by touching contaminated surfaces.
2. Conjunctivitis caused by enterovirus: This type of conjunctivitis is also highly contagious and can be spread through contact with an infected person's saliva, mucus, or feces.
3. Herpetic keratitis: This is a rare form of viral eye infection that is caused by the herpes simplex virus and can lead to serious complications if left untreated.
4. Epidemic keratoconjunctivitis: This is a highly contagious form of conjunctivitis that is caused by adenovirus and can affect both children and adults.
Viral eye infections are typically diagnosed through a comprehensive eye exam, which may include a visual acuity test, a dilated eye exam, and/or a viral culture. Treatment for viral eye infections usually involves antiviral medication, cold compresses, and good hygiene practices to prevent the spread of the infection.
Prevention:
To prevent the spread of viral eye infections, it is important to practice good hygiene habits such as washing your hands frequently, avoiding close contact with people who are infected, and not sharing personal items like towels or makeup. If you have a viral eye infection, it is also important to avoid touching your eyes and to cover your mouth and nose when coughing or sneezing.
Conclusion:
Viral eye infections can be highly contagious and cause uncomfortable symptoms such as redness, discharge, and blurred vision. It is important to seek medical attention if you experience any of these symptoms, as they can lead to serious complications if left untreated. Good hygiene practices and antiviral medication can help prevent and treat viral eye infections.
There are many different types of retinal degeneration, each with its own set of symptoms and causes. Some common forms of retinal degeneration include:
1. Age-related macular degeneration (AMD): This is the most common form of retinal degeneration and affects the macula, the part of the retina responsible for central vision. AMD can cause blind spots or distorted vision.
2. Retinitis pigmentosa (RP): This is a group of inherited conditions that affect the retina and can lead to night blindness, loss of peripheral vision, and eventually complete vision loss.
3. Leber congenital amaurosis (LCA): This is a rare inherited condition that causes severe vision loss or blindness at birth or within the first few years of life.
4. Stargardt disease: This is a rare inherited condition that causes progressive vision loss and can lead to blindness.
5. Retinal detachment: This occurs when the retina becomes separated from the underlying tissue, causing vision loss.
6. Diabetic retinopathy (DR): This is a complication of diabetes that can cause damage to the blood vessels in the retina and lead to vision loss.
7. Retinal vein occlusion (RVO): This occurs when a blockage forms in the small veins that carry blood away from the retina, causing vision loss.
There are several risk factors for retinal degeneration, including:
1. Age: Many forms of retinal degeneration are age-related and become more common as people get older.
2. Family history: Inherited conditions such as RP and LCA can increase the risk of retinal degeneration.
3. Genetics: Some forms of retinal degeneration are caused by genetic mutations.
4. Diabetes: Diabetes is a major risk factor for diabetic retinopathy, which can cause vision loss.
5. Hypertension: High blood pressure can increase the risk of retinal vein occlusion and other forms of retinal degeneration.
6. Smoking: Smoking has been linked to an increased risk of several forms of retinal degeneration.
7. UV exposure: Prolonged exposure to UV radiation from sunlight can increase the risk of retinal degeneration.
There are several treatment options for retinal degeneration, including:
1. Vitamin and mineral supplements: Vitamins A, C, and E, as well as zinc and selenium, have been shown to slow the progression of certain forms of retinal degeneration.
2. Anti-vascular endothelial growth factor (VEGF) injections: These medications can help reduce swelling and slow the progression of diabetic retinopathy and other forms of retinal degeneration.
3. Photodynamic therapy: This involves the use of a light-sensitive medication and low-intensity laser light to damage and shrink abnormal blood vessels in the retina.
4. Retinal implants: These devices can be used to restore some vision in people with advanced forms of retinal degeneration.
5. Stem cell therapy: Research is ongoing into the use of stem cells to repair damaged retinal cells and restore vision.
It's important to note that early detection and treatment of retinal degeneration can help to slow or stop the progression of the disease, preserving vision for as long as possible. Regular eye exams are crucial for detecting retinal degeneration in its early stages, when treatment is most effective.
Examples of AROIs include:
1. Pneumocystis pneumonia (PCP): a type of pneumonia caused by the fungus Pneumocystis jirovecii.
2. Tuberculosis (TB): a bacterial infection that can affect the lungs, brain, or other organs.
3. Toxoplasmosis: an infection caused by the parasite Toxoplasma gondii that can affect the brain, eyes, and other organs.
4. Cryptococcosis: a fungal infection that can affect the lungs, brain, or skin.
5. Histoplasmosis: a fungal infection caused by Histoplasma capsulatum that can affect the lungs, skin, and other organs.
6. Aspergillosis: a fungal infection caused by Aspergillus species that can affect the lungs, sinuses, and other organs.
7. Candidiasis: a fungal infection caused by Candida species that can affect the mouth, throat, vagina, or skin.
8. Kaposi's sarcoma: a type of cancer that is caused by the human herpesvirus 8 (HHV-8) and can affect the skin and lymph nodes.
9. Wasting syndrome: a condition characterized by weight loss, fatigue, and diarrhea.
10. Opportunistic infections that can affect the gastrointestinal tract, such as cryptosporidiosis and isosporiasis.
AROIs are a major cause of morbidity and mortality in individuals with HIV/AIDS, and they can be prevented or treated with antimicrobial therapy, supportive care, and other interventions.
Examples of X-linked genetic diseases include:
* Hemophilia A and B
* Duchenne muscular dystrophy
* Connexin 26 (GJB2) deafness
* Fragile X syndrome
* X-linked mental retardation
* Juvenile primary lateral sclerosis
* Myotonic dystrophy type 1
X-linked diseases can be caused by mutations in various genes, including those involved in blood clotting, muscle function, and hearing. These conditions often have a significant impact on quality of life and can be inherited from one generation to the next. However, advances in medical technology and research offer hope for improved treatments and potential cures.
Prevention of X-linked diseases is challenging but possible through various methods such as:
1. Genetic counseling: Providing information about the risks and inheritance patterns of X-linked conditions to families can help them make informed decisions about their reproductive options.
2. Prenatal testing: Testing the fetus during pregnancy can identify X-linked mutations and allow for appropriate planning and decision-making.
3. Carrier testing: Identifying carriers of X-linked conditions can help families understand their risk and make informed decisions about their reproductive options.
4. Gene therapy: Experimental treatments that correct or replace the faulty gene responsible for the condition offer hope for improved outcomes.
5. Treatment and management: Various therapeutic approaches, including medication, physical therapy, and surgery, can help manage symptoms and improve quality of life.
In conclusion, X-linked genetic diseases are a significant portion of inherited disorders that have a profound impact on families and individuals affected by them. While there is no cure for these conditions, advances in medical technology and research offer hope for improved treatments and potential cures. By understanding the causes, symptoms, diagnosis, and prevention methods, families can make informed decisions about their reproductive options and receive appropriate care and support.
The symptoms of acute RNS may include:
1. Severe eye pain
2. Blurred vision or loss of vision
3. Sensitivity to light
4. Redness and swelling of the eye
5. Floaters (specks or cobwebs in vision)
6. Flashes of light
The exact cause of acute RNS is not known, but it is believed to be related to a viral or bacterial infection, trauma, or systemic diseases such as diabetes, high blood pressure, and autoimmune disorders.
Diagnosis of acute RNS typically involves a comprehensive eye exam, including imaging tests such as fluorescein angiography and optical coherence tomography (OCT) to evaluate the retina and optic nerve. Laboratory tests may also be ordered to rule out other causes of vision loss.
Treatment for acute RNS is focused on addressing the underlying cause and managing symptoms. This may include antiviral or antibacterial medications, corticosteroids, and pain management. In severe cases, surgery may be necessary to remove damaged tissue or repair the retina.
Prognosis for acute RNS varies depending on the underlying cause and severity of the condition. In some cases, vision loss may be permanent, while in others, vision can improve with treatment. Prompt medical attention is essential to minimize visual loss and prevent complications.
Causes: There are several causes of night blindness, including:
1. Vitamin A deficiency: Vitamin A is essential for the health of the retina, and a deficiency can lead to night blindness.
2. Retinitis pigmentosa: This is a group of inherited conditions that can cause progressive damage to the retina and result in night blindness.
3. Cataracts: A cataract can cause a person to become night blind by blocking the light that enters the eye.
4. Glaucoma: This is a group of eye conditions that can damage the optic nerve and lead to vision loss, including night blindness.
5. Other medical conditions: Certain medical conditions such as diabetes, multiple sclerosis, and stroke can cause night blindness.
Symptoms: The symptoms of night blindness can vary depending on the underlying cause, but common symptoms include:
1. Difficulty seeing in low light environments
2. Blind spots or missing areas of vision
3. Sensitivity to light
4. Glare or halos around lights
5. Difficulty adjusting to changes in light levels
Diagnosis: Night blindness is typically diagnosed through a comprehensive eye exam, which may include a visual acuity test, refraction test, and retinal examination. Imaging tests such as an OCT scan or retinal photography may also be used to evaluate the retina and optic nerve.
Treatment: The treatment of night blindness depends on the underlying cause. For example, vitamin A supplements may be prescribed for a vitamin A deficiency, while cataract surgery may be recommended for cataracts. In some cases, no treatment may be necessary, and the condition may resolve on its own over time.
Prevention: While some cases of night blindness are unavoidable, there are steps you can take to reduce your risk of developing the condition. These include:
1. Maintaining a healthy diet that includes foods rich in vitamin A and other essential nutrients for eye health.
2. Wearing sunglasses with UV protection to protect your eyes from excessive sunlight.
3. Avoiding smoking and excessive alcohol consumption, which can damage the optic nerve and retina.
4. Getting regular eye exams to detect any underlying eye problems early on.
5. Wearing protective eyewear when engaging in activities that could potentially harm your eyes, such as sports or working with hazardous materials.
The Usher syndromes are a group of rare genetic disorders that affect both hearing and vision. They are caused by mutations in specific genes and can be inherited in an autosomal recessive or X-linked manner. The syndromes are characterized by progressive retinal degeneration, hearing loss, and vestibular dysfunction.
Source: National Institute on Deafness and Other Communication Disorders (NIDCD)
Note: This is a medical definition, and the term "Usher Syndromes" is not commonly used in everyday conversation. It is used primarily in the medical field to describe this specific group of disorders.
There are different types of blindness, including:
1. Congenital blindness: Blindness that is present at birth, often due to genetic mutations or abnormalities in the development of the eye and brain.
2. Acquired blindness: Blindness that develops later in life due to injury, disease, or other factors.
3. Amblyopia: A condition where one eye has reduced vision due to misalignment or other causes.
4. Glaucoma: A group of eye conditions that can damage the optic nerve and lead to blindness if left untreated.
5. Retinitis pigmentosa: A degenerative disease that affects the retina and can cause blindness.
6. Cataracts: A clouding of the lens in the eye that can impair vision and eventually cause blindness if left untreated.
7. Macular degeneration: A condition where the macula, a part of the retina responsible for central vision, deteriorates and causes blindness.
There are various treatments and therapies for blindness, depending on the underlying cause. These may include medications, surgery, low vision aids, and assistive technology such as braille and audio books, screen readers, and voice-controlled software. Rehabilitation programs can also help individuals adapt to blindness and lead fulfilling lives.
Examples of retinal diseases include:
1. Age-related macular degeneration (AMD): a leading cause of vision loss in people over the age of 50, AMD affects the macula, the part of the retina responsible for central vision.
2. Diabetic retinopathy (DR): a complication of diabetes that damages blood vessels in the retina and can cause blindness.
3. Retinal detachment: a condition where the retina becomes separated from the underlying tissue, causing vision loss.
4. Macular edema: swelling of the macula that can cause vision loss.
5. Retinal vein occlusion (RVO): a blockage of the small veins in the retina that can cause vision loss.
6. Retinitis pigmentosa (RP): a group of inherited disorders that affect the retina and can cause progressive vision loss.
7. Leber congenital amaurosis (LCA): an inherited disorder that causes blindness or severe visual impairment at birth or in early childhood.
8. Stargardt disease: a rare inherited disorder that affects the retina and can cause progressive vision loss, usually starting in childhood.
9. Juvenile macular degeneration: a rare inherited disorder that causes vision loss in young adults.
10. Retinal dystrophy: a group of inherited disorders that affect the retina and can cause progressive vision loss.
Retinal diseases can be diagnosed with a comprehensive eye exam, which includes a visual acuity test, dilated eye exam, and imaging tests such as optical coherence tomography (OCT) or fluorescein angiography. Treatment options vary depending on the specific disease and can include medication, laser surgery, or vitrectomy.
It's important to note that many retinal diseases can be inherited, so if you have a family history of eye problems, it's important to discuss your risk factors with your eye doctor. Early detection and treatment can help preserve vision and improve quality of life for those affected by these diseases.
Some common types of vision disorders include:
1. Myopia (nearsightedness): A condition where close objects are seen clearly, but distant objects appear blurry.
2. Hyperopia (farsightedness): A condition where distant objects are seen clearly, but close objects appear blurry.
3. Astigmatism: A condition where the cornea or lens of the eye is irregularly shaped, causing blurred vision at all distances.
4. Presbyopia: A condition that occurs as people age, where the lens of the eye loses flexibility and makes it difficult to focus on close objects.
5. Amblyopia (lazy eye): A condition where one eye has reduced vision due to abnormal development or injury.
6. Strabismus (crossed eyes): A condition where the eyes are misaligned and point in different directions.
7. Color blindness: A condition where people have difficulty perceiving certain colors, usually red and green.
8. Retinal disorders: Conditions that affect the retina, such as age-related macular degeneration, diabetic retinopathy, or retinal detachment.
9. Glaucoma: A group of conditions that damage the optic nerve, often due to increased pressure in the eye.
10. Cataracts: A clouding of the lens in the eye that can cause blurred vision and sensitivity to light.
Vision disorders can be diagnosed through a comprehensive eye exam, which includes a visual acuity test, refraction test, and dilated eye exam. Treatment options for vision disorders depend on the specific condition and may include glasses or contact lenses, medication, surgery, or a combination of these.
1. Retinitis pigmentosa (RP): a group of degenerative diseases that affect the retina and cause progressive vision loss.
2. Leber congenital amaurosis (LCA): a rare inherited disorder that causes blindness or severe visual impairment at birth or in early childhood.
3. Stargardt disease: a genetic disorder that affects the retina and can cause progressive vision loss, usually starting in childhood.
4. Juvenile macular degeneration (JMD): a group of inherited conditions that affect the macula, the part of the retina responsible for central vision.
5. Persistent hyperplastic primary vitreous (PHPV): a rare inherited condition where abnormal development of the eye can cause vision loss or blindness.
6. Anophthalmia/microphthalmia: a rare inherited condition where one or both eyes are absent or severely underdeveloped.
7. ocular albinism: a genetic condition that affects the development of pigment in the eye, leading to visual impairment and increased risk of eye conditions such as cataracts and glaucoma.
8. Peter's anomaly: a rare inherited condition where there is an abnormal development of the cornea and lens of the eye, leading to vision loss or blindness.
9. cone-rod dystrophy: a group of inherited conditions that affect the retina and can cause progressive vision loss, usually starting in childhood.
10. Retinal dystrophy: a general term for a group of inherited disorders that affect the retina and can cause progressive vision loss, usually starting in adulthood.
These are just a few examples of hereditary eye diseases. There are many other conditions that can be inherited and affect the eyes. Genetic testing and counseling can help identify the risk of inheriting these conditions and provide information on how to manage and treat them.
The symptoms of AIDS can vary depending on the individual and the stage of the disease. Common symptoms include:
1. Fever
2. Fatigue
3. Swollen glands
4. Rash
5. Muscle aches and joint pain
6. Night sweats
7. Diarrhea
8. Weight loss
9. Memory loss and other neurological problems
10. Cancer and other opportunistic infections.
AIDS is diagnosed through blood tests that detect the presence of HIV antibodies or the virus itself. There is no cure for AIDS, but antiretroviral therapy (ART) can help manage the symptoms and slow the progression of the disease. Prevention methods include using condoms, pre-exposure prophylaxis (PrEP), and avoiding sharing needles or other injection equipment.
In summary, Acquired Immunodeficiency Syndrome (AIDS) is a severe and life-threatening condition caused by the Human Immunodeficiency Virus (HIV). It is characterized by a severely weakened immune system, which makes it difficult to fight off infections and diseases. While there is no cure for AIDS, antiretroviral therapy can help manage the symptoms and slow the progression of the disease. Prevention methods include using condoms, pre-exposure prophylaxis, and avoiding sharing needles or other injection equipment.
The diagnosis is based on a physical examination of the eye and can be confirmed by laboratory tests such as PCR or viral culture. Treatment usually involves antiviral medication to reduce pain and prevent complications, and topical steroids to reduce inflammation. In severe cases, corticosteroid injections may be recommended to reduce swelling and prevent scarring.
Preventive measures include avoiding close contact with people who have chickenpox or shingles, practicing good hygiene such as frequent hand-washing and avoiding sharing personal items like towels or makeup. Vaccination is also recommended to prevent the development of herpes zoster ophthalmicus in people who have previously had chickenpox or shingles.
Prognosis for this condition is generally good if treated promptly, and most people recover completely within a few days to weeks. However, complications can include scarring of the cornea, vision loss, and eye inflammation that can lead to permanent blindness. It is important to seek medical attention immediately if symptoms persist or worsen over time.
There are several different types of uveitis, including:
1. Anterior uveitis: This type affects the front part of the eye and is the most common form of uveitis. It is often caused by an infection or injury.
2. Posterior uveitis: This type affects the back part of the eye and can be caused by a systemic disease such as sarcoidosis or juvenile idiopathic arthritis.
3. Intermediate uveitis: This type affects the middle layer of the eye and is often caused by an autoimmune disorder.
4. Panuveitis: This type affects the entire uvea and can be caused by a systemic disease such as vasculitis or Behçet's disease.
Symptoms of uveitis may include:
* Eye pain
* Redness and swelling in the eye
* Blurred vision
* Sensitivity to light
* Floaters (specks or cobwebs in your vision)
* Flashes of light
If you experience any of these symptoms, it is important to see an eye doctor as soon as possible. Uveitis can be diagnosed with a comprehensive eye exam, which may include imaging tests such as ultrasound or MRI. Treatment for uveitis depends on the cause and severity of the condition, but may include medication to reduce inflammation, antibiotics for infections, or surgery to remove any diseased tissue.
Early diagnosis and treatment are important to prevent complications such as cataracts, glaucoma, and blindness. If you have uveitis, it is important to follow your doctor's recommendations for treatment and monitoring to protect your vision.
The term "Leber" refers to the fact that the disorder was first described by the German ophthalmologist Theodor Leber in 1869. The word "congenital" indicates that the condition is present at birth, and "amaurosis" means darkness or blindness.
LCA is caused by mutations in genes that are essential for normal retinal development and function, such as the RPE65 gene, the LCA2 gene, or the CRB1 gene. The inheritance pattern of LCA is usually autosomal recessive, meaning that a child must inherit two copies of the defective gene, one from each parent, to develop the condition.
There is currently no cure for LCA, and treatment is limited to managing associated complications such as cataracts or glaucoma. Low vision aids and mobility training can also help individuals with LCA to make the most of their remaining vision. Research into gene therapy and stem cell-based treatments holds promise for improving the prognosis for individuals with LCA in the future.
Laurence-Moon syndrome is a rare genetic disorder that affects the development of the brain and nervous system. It is characterized by intellectual disability, seizures, and distinctive physical features such as a flat face, short stature, and thin limbs. The syndrome is caused by mutations in the TCF4 gene and is usually inherited in an autosomal dominant pattern.
The name "Laurence-Moon" was chosen to honor two British physicians who first described the condition in the early 20th century: Sir James Laurence and Dr. Mary Moon. The syndrome is also known as Haploinsufficiiency- intellectual disability syndrome, or HIDS for short.
Causes and Symptoms of Laurence-Moon Syndrome:
Laurence-Moon syndrome is caused by mutations in the TCF4 gene, which plays a crucial role in the development and maintenance of the nervous system. The mutations lead to a deficiency of functional TCF4 protein, resulting in impaired neural development and function.
The symptoms of Laurence-Moon syndrome can vary in severity and may include:
1. Intellectual disability: Affected individuals usually have below-average intelligence and may struggle with speech, language, and cognitive skills.
2. Seizures: Epilepsy is a common feature of the syndrome, and seizures can begin at any age.
3. Distinctive physical features: The syndrome is characterized by a flat face, short stature, thin limbs, and a small head (microcephaly).
4. Behavioral problems: Affected individuals may exhibit behavioral problems such as anxiety, hyperactivity, and aggression.
5. Sleep disturbances: Laurence-Moon syndrome can cause sleep disruptions and difficulty falling asleep or staying asleep.
6. Vision problems: Some individuals with the condition may experience vision loss, cataracts, or other eye abnormalities.
7. Hearing impairment: Hearing loss or deafness is a common feature of Laurence-Moon syndrome.
8. Dysmorphism: Affected individuals may have unusual physical characteristics, such as a large head or facial features that are not typical for their age.
9. Growth delays: Children with Laurence-Moon syndrome may experience delayed growth and development, leading to short stature.
10. Immunodeficiency: Some individuals with the condition may have a weakened immune system, making them more susceptible to infections.
Laurence-Moon syndrome is a rare genetic disorder that affects approximately one in 1 million people worldwide. The condition is caused by mutations in the TCF4 gene, which plays a critical role in the development and function of the nervous system. There is currently no cure for Laurence-Moon syndrome, but researchers are working to develop new treatments that can help manage the symptoms and improve the quality of life for affected individuals.
Symptoms of chorioretinitis may include blurred vision, sensitivity to light, floaters, and flashes of light. Diagnosis is typically made through a combination of physical examination, imaging tests such as fluorescein angiography or optical coherence tomography, and laboratory testing to rule out other conditions.
Treatment for chorioretinitis usually involves antibiotics or antiviral medication to clear the infection, as well as steroids to reduce inflammation. In severe cases, surgery may be necessary to remove the affected area of the retina. Prognosis is generally good if the disease is caught early and treated promptly, but vision loss may occur if the disease is left untreated for an extended period of time.
Some common types of eye infections include:
1. Conjunctivitis - a highly contagious infection of the conjunctiva, which is the thin membrane that covers the white part of the eye and the inside of the eyelids. It can be caused by bacteria or virus and is commonly known as pink eye.
2. Keratitis - an inflammation of the cornea, which is the clear dome-shaped surface at the front of the eye. It can be caused by bacteria, virus or fungi.
3. Uveitis - an inflammation of the uvea, which is the layer of tissue between the sclera and retina. It can cause pain, sensitivity to light and blurred vision.
4. Endophthalmitis - a severe infection inside the eye that can cause damage to the lens, retina and other structures. It is usually caused by bacteria or fungi and can be a complication of cataract surgery or other eye procedures.
5. Dacryocystitis - an inflammation of the tear ducts and sac that can cause pain, redness and swelling in the eyelid. It is usually caused by bacteria.
Eye infections can be diagnosed through a comprehensive eye exam, which may include a visual acuity test, dilated eye exam, tonometry and imaging tests such as ultrasound or CT scans. Treatment depends on the type of infection and severity of the condition, and may involve antibiotic or antiviral medication, anti-inflammatory medication or surgery. It is important to seek medical attention if symptoms persist or worsen over time, as untreated eye infections can lead to complications such as vision loss, corneal scarring and even blindness.
Types of Retinal Dysplasia:
1. Retinal dysplasia with macular involvement: This type affects the macula, the central part of the retina responsible for central vision. It can cause blurred vision, distorted vision, and difficulty reading or recognizing faces.
2. Retinal dysplasia without macular involvement: This type affects the peripheral retina and can cause peripheral vision loss.
3. Coloboma of the retina: This is a rare type of retinal dysplasia that affects the optic nerve and can cause blind spots in the visual field.
4. Retinal pigment epithelial dysplasia: This type affects the layer of cells underneath the retina and can cause vision problems or blindness.
Causes of Retinal Dysplasia:
1. Genetics: Many cases of retinal dysplasia are inherited, with genetic mutations passed down from parents to children.
2. Premature birth: Babies born prematurely are at a higher risk of developing retinal dysplasia.
3. Maternal infection during pregnancy: Certain infections, such as rubella or toxoplasmosis, can increase the risk of retinal dysplasia in the developing fetus.
4. Trauma: In some cases, retinal dysplasia may be caused by trauma to the eye during fetal development or early childhood.
Symptoms of Retinal Dysplasia:
1. Blurred vision
2. Distorted vision
3. Difficulty reading or recognizing faces
4. Peripheral vision loss
5. Blind spots in the visual field (in severe cases)
Diagnosis of Retinal Dysplasia:
1. Ophthalmological examination: An eye doctor will perform a comprehensive eye exam to assess vision and examine the retina using an ophthalmoscope or ultrasound.
2. Electrooculography (EOG): This test measures the electrical activity of the retina and can help identify any abnormalities.
3. Visual evoked potentials (VEP): This test measures the response of the retina to visual stimuli and can help identify any abnormalities.
4. Genetic testing: In some cases, genetic testing may be performed to identify genetic mutations associated with retinal dysplasia.
Treatment of Retinal Dysplasia:
1. Glasses or contact lenses: In mild cases, corrective lenses can help improve vision.
2. Vitamin A supplements: Vitamin A is essential for healthy retinal function, and deficiencies can exacerbate retinal dysplasia.
3. Laser therapy: Focal laser therapy can be used to reduce the size of lesions and improve vision.
4. Photodynamic therapy: This involves the use of a light-sensitive medication and low-intensity laser light to damage and shrink abnormal retinal tissue.
5. Retinal detachment surgery: In cases where retinal dysplasia has led to retinal detachment, surgery may be necessary to reattach the retina.
6. Vitrectomy: In severe cases of retinal dysplasia, a vitrectomy (removal of the vitreous gel) may be performed to relieve symptoms and improve vision.
It is important to note that the prognosis for retinal dysplasia can vary depending on the severity of the condition and the presence of any underlying conditions. In some cases, retinal dysplasia may resolve on its own over time, while in other cases, it may lead to permanent vision loss if left untreated. Regular follow-up appointments with an eye doctor are essential for monitoring the condition and determining the best course of treatment.
CMV infections are more common in people with weakened immune systems, such as those with HIV/AIDS, cancer, or taking immunosuppressive drugs after an organ transplant. In these individuals, CMV can cause severe and life-threatening complications, such as pneumonia, retinitis (inflammation of the retina), and gastrointestinal disease.
In healthy individuals, CMV infections are usually mild and may not cause any symptoms at all. However, in some cases, CMV can cause a mononucleosis-like illness with fever, fatigue, and swollen lymph nodes.
CMV infections are diagnosed through a combination of physical examination, blood tests, and imaging studies such as CT scans or MRI. Treatment is generally not necessary for mild cases, but may include antiviral medications for more severe infections. Prevention strategies include avoiding close contact with individuals who have CMV, practicing good hygiene, and considering immunoprophylaxis (prevention of infection through the use of immune globulin) for high-risk individuals.
Overall, while CMV infections can be serious and life-threatening, they are relatively rare in healthy individuals and can often be treated effectively with supportive care and antiviral medications.
There are many different types of eye diseases, including:
1. Cataracts: A clouding of the lens in the eye that can cause blurry vision and blindness.
2. Glaucoma: A group of diseases that damage the optic nerve and can lead to vision loss and blindness.
3. Age-related macular degeneration (AMD): A condition that causes vision loss in older adults due to damage to the macula, the part of the retina responsible for central vision.
4. Diabetic retinopathy: A complication of diabetes that can cause damage to the blood vessels in the retina and lead to vision loss.
5. Detached retina: A condition where the retina becomes separated from the underlying tissue, leading to vision loss.
6. Macular hole: A small hole in the macula that can cause vision loss.
7. Amblyopia (lazy eye): A condition where one eye is weaker than the other and has reduced vision.
8. Strabismus (crossed eyes): A condition where the eyes are not aligned properly and point in different directions.
9. Conjunctivitis: An inflammation of the conjunctiva, the thin membrane that covers the white part of the eye and the inside of the eyelids.
10. Dry eye syndrome: A condition where the eyes do not produce enough tears, leading to dryness, itchiness, and irritation.
Eye diseases can be caused by a variety of factors, including genetics, age, environmental factors, and certain medical conditions. Some eye diseases are inherited, while others are acquired through lifestyle choices or medical conditions.
Symptoms of eye diseases can include blurry vision, double vision, eye pain, sensitivity to light, and redness or inflammation in the eye. Treatment options for eye diseases depend on the specific condition and can range from medication, surgery, or lifestyle changes.
Regular eye exams are important for detecting and managing eye diseases, as many conditions can be treated more effectively if caught early. If you experience any symptoms of eye disease or have concerns about your vision, it is important to see an eye doctor as soon as possible.
1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.
2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.
3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.
4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.
5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.
6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.
7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.
8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.
9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.
10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.
Ocular toxoplasmosis is more common in people with compromised immune systems, such as those with HIV/AIDS or undergoing immunosuppressive therapy following an organ transplant. It can also occur in individuals who have been exposed to the parasite through contact with contaminated soil, cat feces, or undercooked meat.
Symptoms of ocular toxoplasmosis can include blurred vision, eye pain, sensitivity to light, and floaters. If left untreated, the infection can lead to vision loss, retinal detachment, and even blindness.
Diagnosis is typically made through a combination of physical examination, laboratory tests (such as polymerase chain reaction or serology), and imaging studies (such as ultrasonography or fluorescein angiography). Treatment typically involves antibiotics and anti-inflammatory medications, and in severe cases, surgery may be necessary.
Preventive measures include avoiding contact with cat feces, properly cooking meat, and avoiding undercooked meat, especially pork and lamb. Pregnant women should also take precautions to avoid exposure, as toxoplasmosis can be transmitted to the fetus and cause congenital infection.
Definition of 'Optic Atrophy, Hereditary, Leber' in the medical field. (2018, February 27). In Medical News Today, . Retrieved from
Examples of syndromes include:
1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.
Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.
There are several types of ataxia, each with different symptoms and causes. Some common forms of ataxia include:
1. Spinocerebellar ataxia (SCA): This is the most common form of ataxia and is caused by a degeneration of the cerebellum and spinal cord. It can cause progressive weakness, loss of coordination, and difficulty with speaking and swallowing.
2. Friedreich's ataxia: This is the second most common form of ataxia and is caused by a deficiency of vitamin E in the body. It can cause weakness in the legs, difficulty walking, and problems with speech and language.
3. Ataxia-telangiectasia (AT): This is a rare form of ataxia that is caused by a gene mutation. It can cause progressive weakness, loss of coordination, and an increased risk of developing cancer.
4. Acute cerebellar ataxia: This is a sudden and temporary form of ataxia that can be caused by a variety of factors such as infections, injuries, or certain medications.
5. Drug-induced ataxia: Certain medications can cause ataxia as a side effect.
6. Vitamin deficiency ataxia: Deficiencies in vitamins such as vitamin B12 or folate can cause ataxia.
7. Metabolic disorders: Certain metabolic disorders such as hypothyroidism, hyperthyroidism, and hypoglycemia can cause ataxia.
8. Stroke or brain injury: Ataxia can be a result of a stroke or brain injury.
9. Multiple system atrophy (MSA): This is a rare progressive neurodegenerative disorder that can cause ataxia, parkinsonism, and autonomic dysfunction.
10. Spinocerebellar ataxia (SCA): This is a group of rare genetic disorders that can cause progressive cerebellar ataxia, muscle wasting, and other signs and symptoms.
It's important to note that this is not an exhaustive list and there may be other causes of ataxia not mentioned here. If you suspect you or someone you know may have ataxia, it is important to consult a healthcare professional for proper diagnosis and treatment.
Symptoms of macular edema may include blurred vision, distorted vision, blind spots, and sensitivity to light. Diagnosis is typically made through a comprehensive eye exam, including a visual acuity test and imaging tests such as optical coherence tomography (OCT).
Treatment for macular edema depends on the underlying cause of the condition. In some cases, medications such as anti-vascular endothelial growth factor (VEGF) injections or corticosteroids may be prescribed to reduce fluid buildup and swelling in the retina. In more severe cases, surgical intervention may be necessary, such as a vitrectomy to remove the vitreous gel and relieve pressure on the retina.
Prevention of macular edema includes managing underlying conditions such as diabetes and age-related macular degeneration, as well as maintaining regular eye exams to detect and treat any changes in the retina early on. Early detection and treatment can help prevent vision loss from macular edema.
1. Vision loss or blindness
2. Developmental delays and intellectual disability
3. Speech and language difficulties
4. Poor coordination and balance
5. Skeletal abnormalities such as short stature, short arms, and curved spine
6. Kidney problems
7. Hearing loss
8. Increased risk of infections
9. Cleft palate or other facial defects
10. Delayed puberty or absent menstruation in females
The syndrome is caused by mutations in the Bardet-Biedl genes, which are responsible for the development and function of the body's sensory and motor systems. It is inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the mutated gene - one from each parent - to develop the condition.
There is currently no cure for Bardet-Biedl Syndrome, but treatment and management options are available to help manage the symptoms and improve quality of life. These may include:
1. Vision aids such as glasses or contact lenses
2. Speech and language therapy
3. Physical therapy to improve coordination and balance
4. Occupational therapy to develop daily living skills
5. Medications to manage infections, seizures, or other complications
6. Surgery to correct physical abnormalities such as cleft palate or spinal deformities
7. Hormone replacement therapy for delayed puberty or absent menstruation in females.
The prognosis for individuals with Bardet-Biedl Syndrome varies depending on the severity of the symptoms and the presence of any additional health issues. With appropriate management and support, many individuals with the condition are able to lead fulfilling lives and achieve their goals. However, the syndrome can be associated with a higher risk of certain health complications, such as kidney disease or respiratory infections, which can impact life expectancy.
There are several types of retinal dystrophies, each with different symptoms and causes. Some common forms of retinal dystrophies include:
1. Retinitis pigmentosa (RP): This is a group of genetic disorders that affect the retina and cause progressive vision loss, usually starting in childhood or adolescence.
2. Leber congenital amaurosis (LCA): This is a rare form of retinal dystrophy that causes blindness or severe visual impairment at birth or during early childhood.
3. Stargardt disease: This is an inherited disorder that affects the retina and causes vision loss, usually starting in childhood or adolescence.
4. Macular degeneration: This is a condition that affects the macula, the part of the retina responsible for central vision. It can cause vision loss and blindness, especially in older adults.
Retinal dystrophies are caused by genetic mutations that affect the structure and function of the retina. They can be inherited from one's parents or occur spontaneously due to a genetic mutation during fetal development. There is currently no cure for retinal dystrophies, but there are various treatments available to slow down the progression of the disease and manage symptoms. These include vitamin supplements, medications, and surgery.
Retinal dystrophies can have a significant impact on an individual's quality of life, affecting their ability to perform daily activities, socialize, and maintain independence. However, advances in medical technology and research have led to new treatments and therapies that offer hope for those affected by these diseases.
The retina is a layer of cells that lines the inside of the eye and senses light to send visual signals to the brain. When the retina becomes detached, it can no longer function properly, leading to vision loss or distortion.
Retinal detachment can be caused by a variety of factors, including:
1. Age-related changes: As we age, the vitreous gel that fills the eye can become more liquid and pull away from the retina, causing a retinal detachment.
2. Injury or trauma: A blow to the head or a penetrating injury can cause a retinal detachment.
3. Medical conditions: Certain conditions, such as diabetes, high blood pressure, and sickle cell disease, can increase the risk of developing a retinal detachment.
4. Genetic factors: Some people may be more prone to developing a retinal detachment due to inherited genetic factors.
Symptoms of retinal detachment may include:
1. Flashes of light: People may see flashes of light in the peripheral vision.
2. Floaters: Specks or cobwebs may appear in the vision, particularly in the periphery.
3. Blurred vision: Blurred vision or distorted vision may occur as the retina becomes detached.
4. Loss of vision: In severe cases, a retinal detachment can cause a complete loss of vision in one eye.
If you experience any of these symptoms, it is important to seek medical attention immediately. A comprehensive eye exam can diagnose a retinal detachment and determine the appropriate treatment.
Treatment for retinal detachment typically involves surgery to reattach the retina to the underlying tissue. In some cases, laser surgery may be used to seal off any tears or holes in the retina that caused the detachment. In more severe cases, a scleral buckle or other device may be implanted to support the retina and prevent further detachment.
In addition to surgical treatment, there are some lifestyle changes you can make to help reduce your risk of developing a retinal detachment:
1. Quit smoking: Smoking has been linked to an increased risk of retinal detachment. Quitting smoking can help reduce this risk.
2. Maintain a healthy blood pressure: High blood pressure can increase the risk of retinal detachment. Monitoring and controlling your blood pressure can help reduce this risk.
3. Wear protective eyewear: If you participate in activities that could potentially cause eye injury, such as sports or working with hazardous materials, wearing protective eyewear can help reduce the risk of retinal detachment.
4. Get regular eye exams: Regular comprehensive eye exams can help detect any potential issues with the retina before they become serious problems.
Overall, a retinal detachment is a serious condition that requires prompt medical attention to prevent long-term vision loss. By understanding the causes and symptoms of retinal detachment, as well as making lifestyle changes to reduce your risk, you can help protect your vision and maintain good eye health.
Low vision is not the same as blindness, but it does affect an individual's ability to perform daily activities such as reading, driving, and recognizing faces. The condition can be treated with low vision aids such as specialized glasses, telescopes, and video magnifiers that enhance visual acuity and improve the ability to see objects and details more clearly.
In the medical field, Low Vision is often used interchangeably with the term "visual impairment" which refers to any degree of vision loss that cannot be corrected by regular glasses or contact lenses. Visual impairment can range from mild to severe and can have a significant impact on an individual's quality of life.
Low Vision is a common condition among older adults, with approximately 20% of people over the age of 65 experiencing some degree of visual impairment. However, Low Vision can also affect younger individuals, particularly those with certain eye conditions such as retinitis pigmentosa or other inherited eye disorders.
Overall, Low Vision is a condition that affects an individual's ability to see clearly and perform daily activities, and it is important for individuals experiencing vision loss to seek medical attention to determine the cause of their symptoms and explore available treatment options.
The term "Murine" refers to the fact that the condition occurs in mice and other rodents. "Acquired Immunodeficiency Syndrome" (AIDS) is a similar condition in humans caused by HIV. The similarity between MAIDS and AIDS lies in their shared origins as retroviral infections, but there are significant differences in the viruses themselves and the symptoms they cause.
Retinitis
Cytomegalovirus retinitis
Retinitis pigmentosa
Retinitis Pigmentosa International
Retinitis pigmentosa GTPase regulator
Neuropathy, ataxia, and retinitis pigmentosa
Posterior column ataxia-retinitis pigmentosa syndrome
Rhizomelic dysplasia, scoliosis, and retinitis pigmentosa
Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome
Glaucoma
Occult macular dystrophy
Tunnel vision
Locus heterogeneity
Saul Merin
Usher syndrome
Visual field
Chaetomium atrobrunneum
Degenerative disease
Vision disorder
Russell Morse Wilder
IDH3B
List of OMIM disorder codes
ABHD12
Theodore Maxwell
Refractive error
Leomon Moreno
Wong Yip Yan
Fomivirsen
Gene therapy of the human retina
Lobucavir
AIDS Ephemera - CMV: Cytomegalic Retinitis button
Retinitis pigmentosa: MedlinePlus Medical Encyclopedia
Retinitis Pigmentosa | National Eye Institute
JCI -
Precision metabolome reprogramming for imprecision therapeutics in retinitis pigmentosa
Ocular Gene Therapy Product for Rare Disease Retinitis Pigmentosa | National Eye Institute
Vitamin A slows progression of retinitis pigmentosa in children - American Academy of Ophthalmology
Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa
Turmeric may treat retinitis pigmentosa eye disease - Fogarty International Center @ NIH
NIH VideoCast - Retinitis Pigmentosa: Genetic Retinal Photoreceptor Degenerations
Molecular Vision: Clinical and genetic investigations of three Moroccan families with retinitis pigmentosa phenotypes
Cidofovir: a new therapy for cytomegalovirus retinitis - PubMed
Search of: Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | retinitis pigmentosa -...
A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis - PubMed
FDA approves first retinal implant for adults with advanced retinitis pigmentosa
retinitis pigmentosa | NIH Intramural Research Program
CMV Retinitis
Retinitis Pigmentosa
RETINITIS PIGMENTOSA
Retinitis Pigmentosa
CMV Retinitis
CMV Retinitis
CMV Retinitis
retinitis Archivi - GIN
Retinitis Pigmentosa - MSich Chronicles
Cytomegalovirus Retinitis - Toronto Notes
Subjects: Retinitis Pigmentosa -- therapy - Digital Collections - National Library of Medicine Search Results
Pigmentosa33
- NEW ORLEANS - For patients with advanced retinitis pigmentosa, the ability to perceive images and movement can be improved with the implantation of a retinal prosthesis, new research has shown. (medscape.com)
- What is retinitis pigmentosa? (nih.gov)
- Retinitis pigmentosa (RP) is a group of rare eye diseases that affect the retina (the light-sensitive layer of tissue in the back of the eye). (nih.gov)
- X-linked retinitis pigmentosa (XLRP) is a devastating form of retinal degeneration, manifesting early in life with symptoms of night blindness, visual field defects, and decreased visual function. (utah.edu)
- Retinitis pigmentosa (RP) is an inherited retinal dystrophy caused by the loss of photoreceptors and characterized by retinal pigment deposits visible on fundus examination. (nih.gov)
- Retinitis pigmentosa is a group of degenerative eye diseases caused by genetic mutations that lead to severe vision loss and blindness. (nih.gov)
- Recently, NEI-funded researchers found that curcumin, the active ingredient in the spice turmeric, may successfully treat some forms of retinitis pigmentosa. (nih.gov)
- This suggests that patients with retinitis pigmentosa could simply take curcumin pills or include turmeric in their diet, rather than have a drug or a gene surgically injected into their eyes. (nih.gov)
- Retinitis pigmentosa (RP) is a genetically heterogenous group of eye diseases in which initial degeneration of rods triggers secondary degeneration of cones, leading to significant loss of daylight, color, and high-acuity vision. (jci.org)
- Retinitis Pigmentosa (RP) is a blinding eye disease characterized by progressive photoreceptor degeneration that affects over 1 million people worldwide. (nih.gov)
- The X-linked form of RP (or XLRP) comprises up to 20% of this disease, with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene accounting for 75% of X-linked retinitis pigmentosa (XLRP) and 15-20% of all inherited retinal degeneration. (nih.gov)
- There are approximately 10-15,000 patients with X-linked retinitis pigmentosa in the US and 230,000 worldwide. (nih.gov)
- Findings from this case-control study support the hypothesis that vitamin A can slow loss of cone function in children with common forms of retinitis pigmentosa (RP). (aao.org)
- To examine the effect of rhodopsin mutations on cone photoreceptors in human retinas with retinitis pigmentosa (RP). (nih.gov)
- Progressive inherited retinal dystrophies, characterized by degeneration of rod photoreceptors and then cone photoreceptors, are known as retinitis pigmentosa (RP), for which 89 genes have been identified. (molvis.org)
- Retinitis pigmentosa (RP) is a disease where part of the eye (the retina) is degenerating over time. (clinicaltrials.gov)
- Retinitis pigmentosa has a silent and slow onset, so much so that patients normally do not visit the ophthalmologist until 15 years after their night blindness starts. (barraquer.com)
- The prognosis for retinitis pigmentosa depends on the form of inheritance and the age of onset. (barraquer.com)
- The characterisation of the mutation of the genes already involved in retinitis pigmentosa and, therefore, the aetiological diagnosis based on DNA analysis , is currently a very expensive and laborious task. (barraquer.com)
- SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, May 04, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company, is pleased to announce that it has completed patient enrollment ahead of schedule in its Phase 1/2a trial of EA-2353 for the treatment of retinitis pigmentosa (RP). (yahoo.com)
- Endogena's most advanced programs target degenerative diseases of the eye, including retinitis pigmentosa and geographic atrophy (secondary to age-related macular degeneration). (yahoo.com)
- Sue & Bill Gross Stem Cell Research Center researchers have reported that a therapy they created to cure retinitis pigmentosa is safe and well-tolerated, with no immunological issues, by the first group of patients enrolled in an ongoing phase I/II clinical trial. (uci.edu)
- Like other parts of the eye, the retina can break down, and retinal diseases, including age-related macular degeneration, retinitis pigmentosa, and diabetic retinopathy, continue to be leading causes of vision loss and blindness worldwide. (nih.gov)
- A recent study led by IRP scientists has uncovered yet another of these genetic variants, a rare mutation that causes the eye disease retinitis pigmentosa. (nih.gov)
- On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa. (myamericannurse.com)
- Modeling Retinitis Pigmentosa with Patient-Derived iPSCs. (bvsalud.org)
- Retinitis pigmentosa (RP) causes blindness in 1 out of 3000-4000 individuals worldwide. (bvsalud.org)
- Retinitis pigmentosa (RP) is a severe form of hereditary blindness characterized by progressive damage to and loss of the light-sensing cells of the retina. (nih.gov)
- There are no approved treatments for retinitis pigmentosa. (nih.gov)
- Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. (nih.gov)
- X-linked forms of retinitis pigmentosa (XLRP) are relatively severe blinding disorders, resulting from progressive photoreceptor dysfunction primarily caused by mutations in RPGR or RP2 gene. (nih.gov)
- IMSEAR at SEARO: Retinitis pigmentosa associated with blepharophimosis, blue dot cataract and primary inferior oblique overaction. (who.int)
- Type 'retinitis pigmentosa' as Condition name and do not choose any terms from autocomplete. (nih.gov)
Cytomegalovirus17
- Cytomegalovirus (CMV) retinitis is a viral infection of the retina of the eye resulting in inflammation. (medlineplus.gov)
- One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis. (psmarketresearch.com)
- Innovation of products focusing on better efficacy, growing demographics and growing economies in the developing countries, such as China and India, are some of the opportunities for global cytomegalovirus retinitis market. (psmarketresearch.com)
- Cytomegalovirus retinitis is eye disease caused due to retina inflammation of eye. (psmarketresearch.com)
- Photophobia, blurred vision, seeing floaters and blind spots are the symptoms of cytomegalovirus retinitis. (psmarketresearch.com)
- Cytomegalovirus retinitis usually affects people with weak immune system, including HIV affected patients. (psmarketresearch.com)
- Various forms of cytomegalovirus retinitis medication are solutions, capsules, tablets and implants. (psmarketresearch.com)
- Cytomegalovirus retinitis is an emergency situation because if a black spot in the visual field appears once, the disease cannot be cured due to its permanent in nature. (psmarketresearch.com)
- Active cytomegalovirus retinitis is generally treated by uveitis or ocular immunology specialist. (psmarketresearch.com)
- Fomivirsen was the first antisense drug approved by the U.S. Food and Drug Administration (FDA) as an intraocular injection for curing cytomegalovirus retinitis. (psmarketresearch.com)
- Increasing incidence of cytomegalovirus retinitis cases, rising government initiatives towards healthcare infrastructure and enhancement of healthcare facilities are some of the major factors driving the global cytomegalovirus retinitis market growth. (psmarketresearch.com)
- Some of the major factors restraining the growth of the global cytomegalovirus retinitis market are lack of awareness among people for different types of eye diseases, rising healthcare cost in developing countries and lack of healthcare insurance. (psmarketresearch.com)
- Majority of the population do not have proper access to primary healthcare services because of poverty and absence of health insurance, which is also hindering the growth of cytomegalovirus retinitis market. (psmarketresearch.com)
- The other major challenge for the global cytomegalovirus retinitis market is lack of approved treatment guidelines by the World Health Organization (WHO). (psmarketresearch.com)
- North America has the largest market for cytomegalovirus retinitis due to improved medical facilities and increasing occurrence of cytomegalovirus retinitis cases in the region. (psmarketresearch.com)
- Asia-Pacific is growing with the highest rate among global cytomegalovirus retinitis market. (psmarketresearch.com)
- In Asia-Pacific, China and India are the two fastest growing cytomegalovirus retinitis markets, attributed to raising government initiatives and support and large population in these countries. (psmarketresearch.com)
Retina1
- CMV retinitis may also lead to retinal detachment , in which the retina detaches from the back of the eye, causing blindness. (medlineplus.gov)
Symptoms1
- Some people with CMV retinitis have no symptoms. (medlineplus.gov)
Adult patients1
- treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). (nih.gov)
Patients1
- Their results earned approval from the FDA (Food and Drug Administration) in the USA in February 2013 for it to be used on patients with retinitis pigmentaria. (barraquer.com)
Treatment1
- If you had CMV retinitis in the past, ask your provider if you need treatment to prevent its return. (medlineplus.gov)
Usually begins2
- Retinitis usually begins in one eye, but often progresses to the other eye. (medlineplus.gov)
- Retinitis usually begins in 1 eye, but often progresses to the other eye. (stlukes-stl.com)
Group1
- CMV retinitis is caused by a member of a group of herpes-type viruses. (medlineplus.gov)
Show1
- Dilation of the pupils and ophthalmoscopy will show signs of CMV retinitis. (medlineplus.gov)
Pigmentosa is a group2
- Retinitis pigmentosa is a group of related eye disorders that cause progressive vision loss. (medlineplus.gov)
- Retinitis pigmentosa is a group of degenerative eye diseases caused by genetic mutations that lead to severe vision loss and blindness. (nih.gov)
Autosomal dominant retinitis pigmentosa3
- Mutations in the RHO gene are the most common cause of autosomal dominant retinitis pigmentosa, accounting for 20 to 30 percent of all cases. (medlineplus.gov)
- Most people with autosomal dominant retinitis pigmentosa have an affected parent and other family members with the disorder. (medlineplus.gov)
- Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. (medscape.com)
Retinal4
- When counseling patients diagnosed with CMV retinitis and their families, retina specialists are encouraged to discuss all sources of potential vision loss, including uveitis , retinal detachment , and cataract development. (medscape.com)
- Adackapara CA, Sunness JS, Dibernardo CW, Melia BM, Dagnelie G. Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. (medscape.com)
- Retinitis pigmentosa (RP) is an inherited retinal dystrophy caused by the loss of photoreceptors and characterized by retinal pigment deposits visible on fundus examination. (nih.gov)
- Like other parts of the eye, the retina can break down, and retinal diseases, including age-related macular degeneration, retinitis pigmentosa, and diabetic retinopathy, continue to be leading causes of vision loss and blindness worldwide. (nih.gov)
Cone-rod dystr3
- Some of the genes associated with retinitis pigmentosa are also associated with other eye diseases, including a condition called cone-rod dystrophy . (medlineplus.gov)
- Cone-rod dystrophy has signs and symptoms similar to those of retinitis pigmentosa. (medlineplus.gov)
- Unilateral retinitis pigmentosa and cone-rod dystrophy. (medscape.com)
Macular4
- Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. (medscape.com)
- Genead MA, Fishman GA. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. (medscape.com)
- Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone. (medscape.com)
- The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review. (medscape.com)
Symptoms2
- When Do Symptoms of Retinitis pigmentosa Begin? (nih.gov)
- The signs and symptoms of retinitis pigmentosa are most often limited to vision loss. (medlineplus.gov)
Mutations7
- Mutations in more than 60 genes are known to cause nonsyndromic retinitis pigmentosa. (medlineplus.gov)
- mutations in this gene are responsible for 10 to 15 percent of all cases of autosomal recessive retinitis pigmentosa. (medlineplus.gov)
- Together, mutations in the RPGR and RP2 genes account for most cases of X-linked retinitis pigmentosa. (medlineplus.gov)
- Allelic Heterogeneity and Genetic Modifier Loci Contribute to Clinical Variation in Males with X-Linked Retinitis Pigmentosa Due to RPGR Mutations. (medscape.com)
- About 70 percent of people with the X-linked form carry mutations that cause loss of function of the retinitis pigmentosa GTPase Regulator (RPGR) gene, which encodes a protein important for maintaining the health of photoreceptors. (nih.gov)
- Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. (nih.gov)
- X-linked forms of retinitis pigmentosa (XLRP) are relatively severe blinding disorders, resulting from progressive photoreceptor dysfunction primarily caused by mutations in RPGR or RP2 gene. (nih.gov)
Cataract2
- CMV retinitis was found to profoundly increase the risk for cataract formation in patients with AIDS. (medscape.com)
- Cataract surgery in retinitis pigmentosa patients. (medscape.com)
Gene4
- Combining gene mapping and phenotype assessment for fast mutation finding in non-consanguineous autosomal recessive retinitis pigmentosa families. (medscape.com)
- This suggests that patients with retinitis pigmentosa could simply take curcumin pills or include turmeric in their diet, rather than have a drug or a gene surgically injected into their eyes. (nih.gov)
- Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. (nih.gov)
- The researchers then tested the gene therapy in a naturally occurring canine form of RPGR X-linked retinitis pigmentosa that appears among some mixed breeds. (nih.gov)
Diseases1
- All patients were evaluated for HIV status (date of CMV retinitis diagnosis, CD4 count, viral load) and the presence of systemic diseases (diabetes, hypertension , hyperlipidemia). (medscape.com)
Usher1
- The most common form of syndromic retinitis pigmentosa is Usher syndrome , which is characterized by the combination of vision loss and hearing loss beginning early in life. (medlineplus.gov)
Males1
- Roughly 1 in 4,000 people are affected and about 10 to 20 percent have a particularly severe form called X-linked retinitis pigmentosa, which predominately affects males, causing night blindness by age 10 and progressive loss of the visual field by age 45. (nih.gov)
Mutation1
- A recent study led by IRP scientists has uncovered yet another of these genetic variants, a rare mutation that causes the eye disease retinitis pigmentosa. (nih.gov)
Treatment1
- treatment of CMV retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS). (nih.gov)
AIDS1
- Cite this: CMV Retinitis and Cataracts in AIDS - Medscape - Oct 25, 2013. (medscape.com)
Clinical1
- This study holds significance to current clinical practices because it provides evidence that CMV retinitis is associated with a higher risk for cataracts. (medscape.com)
Disorders1
- Retinitis pigmentosa (RP) is a group of inherited disorders characterized by progressive peripheral vision loss and night vision difficulties (nyctalopia) that can lead to central vision loss. (medscape.com)
Loss2
- The first sign of retinitis pigmentosa is usually a loss of night vision, which becomes apparent in childhood. (medlineplus.gov)
- The progressive degeneration of these cells causes the characteristic pattern of vision loss that occurs in people with retinitis pigmentosa. (medlineplus.gov)
Types1
- Researchers have identified several major types of nonsyndromic retinitis pigmentosa, which are usually distinguished by their pattern of inheritance: autosomal dominant, autosomal recessive, or X-linked. (medlineplus.gov)
Eyes1
- 0001). When evaluating eyes without cataracts before developing CMV retinitis, the annual incidence of cataracts was 8.1% per eye. (medscape.com)